Virtu Financial LLC Petros Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.68 - $1.49 $36,443 - $79,855	53,594 New	53,594 $44,000
Q1 2022 May 17, 2022	SELL	$1.07 - $3.36 $56,730 - $178,143	-53,019 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.33 - $4.09 $70,515 - $216,847	53,019 New	53,019 $177,000
Q3 2021 Nov 12, 2021	SELL	$1.82 - $3.2 $26,142 - $45,964	-14,364 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.87 - $4.11 $41,224 - $59,036	14,364 New	14,364 $45,000

Ticker PTPI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,708,000
Market Cap $6.42M
Description
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.